How Prostate Cancer is Treated With Ablation - Yale Medicine Explains

Поделиться
HTML-код
  • Опубликовано: 2 авг 2024
  • For more information on prostate cancer or #YaleMedicine, visit: www.yalemedicine.org/news/abl....
    Although prostate cancer is the most common cancer in men, it is highly treatable and can usually be cured if caught early enough. But like any cancer, some cases require immediate attention, and those are the ones urologic oncologists are most focused on treating with various options, including surgery, radiation, and ablation techniques. Prostate cancer occurs when cells in the prostate gland grow and divide uncontrollably, eventually forming a tumor, which can lead to a host of urinary and sexual function issues. Ablation is a relatively new category of treatment that uses energy-heat, cold, or electricity-to destroy cancer cells, explains Preston C. Sprenkle, MD, a Yale Medicine urologic oncologist. The prostate’s location (below the bladder and in front of the rectum) can make treatment challenging because of the possibility of impacting urinary or bowel functions. “My goal is to optimize each patient’s quality of life while giving them the best cancer control,” Dr. Sprenkle says. Ablation treatments, he says, are extremely precise. Yale physicians offer several different types, including the “TULSA” (transurethral ultrasound ablation) procedure, which is performed while the patient is inside an MRI scanner. “This allows us to outline where the edge of the prostate is in relation to the urethra, rectum, and the nerve bundles, in order to avoid damage to those areas,” Dr. Sprenkle says. In this video, Dr. Sprenkle discusses additional ablation techniques and clinical trials examining prostate cancer treatments.
    0:00 - Prostate Cancer
    1:09 - Prostate Ablation: Precise Targeting of Cancerous Tissue
    2:45 - Precision Medicine: Optimizing Treatments for Each Patient

Комментарии • 2

  • @cartmakers2575
    @cartmakers2575 6 месяцев назад

    Great info! i am very interested in the TULSA and FLA therapy. Reoccuring from 2015 low dose radiation, now a 4+3=7 but lower psa, 2.8-3.6. .With the prior treatment and an Eliquis user my options are limited. I believe these minimally invasive techniques are my answer. Trouble in my area, SW FL, limited options, mostly small clinic non medicare providors. Not sure why since medicare paid for the Artimus fusion MRI Biopsy. Don't mind traveling a bit for the right answer but no solution yet.

  • @TheIcyLady
    @TheIcyLady Год назад

    I was thinking if sequencing prostate tumour tissue collected during biopsy could help in differentiating agressive from not agressive prostate cancers...